Rankings
▼
Calendar
RYTM
Rhythm Pharmaceuticals, Inc.
$6B
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$11M
Net Income
-$11M
EPS (Diluted)
$-1.09
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$298,000
Balance Sheet
Total Assets
$37M
Total Liabilities
$5M
Stockholders' Equity
$32M
Cash & Equivalents
$35M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$11M
-$6M
-62.8%
Net Income
-$11M
-$6M
-70.5%
← FY 2014
All Quarters
Q1 2016 →
RYTM FY 2015 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena